Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Research & Development: ﷼0 Mil (TTM As of Mar. 2026)


SAU:4013 Dr Sulaiman Al Habib Medical Services Group SAU:4013
92 GF Score
Price ﷼212.80
GF Value ﷼396.06
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dr Sulaiman Al Habib Medical Services Group Research & Development?

Dr Sulaiman Al Habib Medical Services Group SAU:4013 -0.47% 92 Research & Development is ﷼0 Mil as of Mar. 2026. GuruFocus rates SAU:4013 with a GF Score™ of 92/100 and a GF Value™ of ﷼396.06 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dr Sulaiman Al Habib Medical Services Group's Research & Development for the three months ended in Mar. 2026 was ﷼0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼0 Mil.

Dr Sulaiman Al Habib Medical Services Group  (SAU:4013) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dr Sulaiman Al Habib Medical Services Group Research & Development Related Terms

Dr Sulaiman Al Habib Medical Services Group Research & Development Historical Data

* Premium members only.

The historical data trend for Dr Sulaiman Al Habib Medical Services Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Sulaiman Al Habib Medical Services Group Research & Development Chart

Dr Sulaiman Al Habib Medical Services Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Dr Sulaiman Al Habib Medical Services Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SAU:4013
92GF Score
Dr Sulaiman Al Habib Medical Services Group SAU:4013
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Sulaiman Al Habib Medical Services Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ﷼0 Mil mean?
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a Research & Development of ﷼0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors.
Is Dr Sulaiman Al Habib Medical Services Group's Research & Development too high?
Dr Sulaiman Al Habib Medical Services Group's current Research & Development is ﷼0 Mil. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's Research & Development compare to HCA and THC?
Dr Sulaiman Al Habib Medical Services Group's Research & Development of ﷼0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. Dr Sulaiman Al Habib Medical Services Group's current Research & Development is ﷼0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼396.06, compared to a current price of ﷼212.80 — trading 46.3% below its estimated fair value. The current Research & Development is ﷼0 Mil. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current Research & Development is ﷼0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued. The current stock price of ﷼212.80 is trading 46.3% below its estimated GF Value™ of ﷼396.06. GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.

Key valuation signals for SAU:4013:

  • Research & Development: ﷼0 Mil
  • GF Value™: ﷼396.06 vs. price of ﷼212.80 (46.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr Sulaiman Al Habib Medical Services Group Business Description

Address P.O. Box 301578, Al Olaya District, Riyadh, SAU, 11372
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
92GF Score

Get the complete analysis for SAU:4013

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼212.80
Price
﷼396.06
GF Value